Hanchen Zhang
Multiple factors contribute to the metabolic condition known as diabetes mellitus (DM), which is characterized by recurrent hyperglycemia as a result of inadequate insulin secretion, insulin action, or both. T-lymphocytes aim to destroy beta cells and other similar cells. DM can be successfully treated with pancreatic transplants, Langerhans islets and individual beta cells. Additionally, stem cell therapy for DM treatment is currently popular. The replacement of beta cells, also known as dead pancreatic cells, with stem cells forms the basis of stem cell therapy for DM. The stem cells differentiate into active cells after attaching to the pancreas' tissues. In DM, a catheter is inserted into the pancreatic artery using an X-ray scanner and the procedure takes 90 minutes. The foundation of DM stem cell treatment is the use of stem cells to replace damaged beta cells in the pancreas. Treatments for insulin-dependent diabetes mellitus include pancreatic transplants, individual beta cell transplants and islets of Langerhans.
Comparte este artículo
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 